Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 26, 2026 4.117
October 23, 2026 4.042
October 22, 2026 4.093
October 21, 2026 4.028
October 20, 2026 4.086
October 19, 2026 3.981
October 16, 2026 3.819
October 15, 2026 3.715
October 14, 2026 3.620
October 13, 2026 3.680
October 12, 2026 3.730
October 09, 2026 3.762
October 08, 2026 3.716
October 07, 2026 3.839
October 06, 2026 3.858
October 05, 2026 3.961
October 02, 2026 3.868
October 01, 2026 3.756
September 30, 2026 3.754
September 29, 2026 3.780
September 28, 2026 3.719
September 25, 2026 3.784
September 24, 2026 3.779
September 23, 2026 3.903
September 22, 2026 4.010
Date Value
September 21, 2026 4.093
September 18, 2026 4.020
September 17, 2026 4.327
September 16, 2026 4.268
September 15, 2026 4.264
September 14, 2026 4.246
September 11, 2026 4.259
September 10, 2026 4.272
September 09, 2026 4.206
September 08, 2026 4.214
September 04, 2026 4.271
September 03, 2026 4.343
September 02, 2026 4.421
September 01, 2026 4.372
August 31, 2026 4.353
August 28, 2026 4.392
August 27, 2026 4.53
August 26, 2026 4.554
August 25, 2026 4.559
August 24, 2026 4.527
August 21, 2026 4.477
August 20, 2026 4.448
August 19, 2026 4.649
August 18, 2026 4.584
August 17, 2026 4.618

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Amarin Corp. Plc 0.5724
Prothena Corp. Plc 1.515
Incyte Corp. 3.589
Cue Biopharma, Inc. 41.77
ADC Therapeutics SA --

Price to Book Value Related Metrics